No Data
No Data
Ginkgo Bioworks Falls -7.0%
Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ...
Revenues Tell The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) As Its Stock Soars 48%
Lesaffre Strengthens Its Research, Development & Innovation (RD&I) With the Acquisition of Altar, a Company Owned by Ginkgo Bioworks
Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture